Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.7950
-0.0750 (-8.62%)
Oct 1, 2026, 4:10 PM AEST
Starpharma Holdings Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 11.02 | 15.41 | 23.36 | 35.18 | 49.92 |
Cash & Short-Term Investments | 11.02 | 15.41 | 23.36 | 35.18 | 49.92 |
Cash Growth | -28.51% | -34.04% | -33.60% | -29.52% | -17.49% |
Accounts Receivable | 3.65 | 4.04 | 0.57 | 0.61 | 0.54 |
Other Receivables | 0.73 | 0.19 | 5.77 | 7.62 | 7.3 |
Receivables | 4.39 | 4.23 | 6.34 | 8.24 | 7.84 |
Inventory | 1.66 | 1.92 | 2.41 | 2.77 | 2.82 |
Prepaid Expenses | 0.52 | 1.01 | 0.81 | 0.93 | 0.08 |
Total Current Assets | 17.58 | 22.56 | 32.92 | 47.12 | 60.66 |
Property, Plant & Equipment | 1.44 | 2.86 | 3.9 | 4.96 | 5.52 |
Total Assets | 19.02 | 25.42 | 36.81 | 52.09 | 66.18 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 2.14 | 2.05 | 2.73 | 6.62 | 6.76 |
Accrued Expenses | 1.19 | 1.16 | 1.05 | 1.28 | 1.34 |
Current Portion of Long-Term Debt | 0.36 | 0.44 | 0.78 | 4.78 | - |
Current Portion of Leases | 0.34 | 0.82 | 0.8 | 0.74 | 0.7 |
Current Unearned Revenue | 0.11 | 0.01 | 0.03 | 0 | 0.47 |
Other Current Liabilities | 1.03 | 0.74 | 1.29 | 1.05 | 0.97 |
Total Current Liabilities | 5.17 | 5.23 | 6.66 | 14.47 | 10.23 |
Long-Term Debt | - | - | - | - | 4 |
Long-Term Leases | - | 1.14 | 1.96 | 2.75 | 3.49 |
Pension & Post-Retirement Benefits | 0.08 | 0.06 | 0.08 | 0.05 | 0.06 |
Total Liabilities | 5.24 | 6.42 | 8.7 | 17.27 | 17.78 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 240.75 | 240.75 | 240.75 | 240.72 | 240.67 |
Retained Earnings | -259.82 | -252.35 | -242.36 | -234.2 | -218.56 |
Comprehensive Income & Other | 32.84 | 30.6 | 29.73 | 28.3 | 26.29 |
Shareholders' Equity | 13.78 | 19 | 28.12 | 34.82 | 48.39 |
Total Liabilities & Equity | 19.02 | 25.42 | 36.81 | 52.09 | 66.18 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.71 | 2.4 | 3.53 | 8.27 | 8.19 |
Net Cash (Debt) | 10.31 | 13.01 | 19.83 | 26.91 | 41.73 |
Net Cash Growth | -20.74% | -34.42% | -26.30% | -35.52% | -29.67% |
Net Cash Per Share | 0.02 | 0.03 | 0.05 | 0.07 | 0.10 |
Filing Date Shares Outstanding | 476.85 | 418.22 | 412.37 | 410.49 | 408.44 |
Total Common Shares Outstanding | 420.93 | 418.22 | 412.37 | 410.49 | 408.44 |
Working Capital | 12.41 | 17.33 | 26.26 | 32.65 | 50.43 |
Book Value Per Share | 0.03 | 0.05 | 0.07 | 0.08 | 0.12 |
Tangible Book Value | 13.78 | 19 | 28.12 | 34.82 | 48.39 |
Tangible Book Value Per Share | 0.03 | 0.05 | 0.07 | 0.08 | 0.12 |
Machinery | 4.03 | 3.94 | 3.93 | 3.94 | 4.62 |
Leasehold Improvements | 0.78 | 0.78 | 0.78 | 0.78 | 0.69 |